Infertility: Anxiety and depression associated with blame Higher risks associated with vaginal birth after cesarean, although absolute risk small Abortion pill Mifegymiso prescribed more than 4,000 times since hitting shelves Health Canada says Canadian pharmacies doled out 4,253 doses of the abortion pill Mifegymiso in 2017, the first year it was marketed in this country. Study questions benefit of vaginal estradiol tablet or moisturizer in managing postmenopausal vulvovaginal symptoms Clinical trial finds Rx Vagifem or OTC Replens provides no additional benefit over using placebo New Canadian guidelines for management of hypertension in pregnancy Hypertension Canada issues first evidence-based Canadian recommendations for managing hypertensive disorders in pregnancy Management strategies for newborns of mothers with opioid dependency Comprehensive plan involves infant observation and assessment, nonpharmacologic interventions, and pharmacological treatment when needed Updated Canadian recommendations for secondary prevention of stroke Focus on prevention of ischemic stroke recurrence, including new guidance on pregnancy Mirena intrauterine contraceptive may reduce breast milk production Health Canada examines effect of levonorgestrel intrauterine systems on breast milk production Managing bacterial vaginosis in pregnancy Canadian guidelines provide recommendations on screening and management Study points to link between antidepressant use in pregnancy and autism in children But absolute risk small, so results should not be considered alarming, say researchers First Previous 21 22 23 24 25 Next Last
